Is There a Risk of Monkeypox Workplace Transmission?
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
Key Points: In today’s Recommendation for Industry, we discuss BA.5’s continued transmission and low severity. Read more below. FDA green-lights Novavax vaccine as COVID-19 levels
Key Points: In today’s Recommendation for Industry, we discuss the possibility of COVID transmission from packaging. Read more below. Nitric oxide boosts oxygen in pregnant
Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now
Key Points: In today’s Recommendation for Industry, we provide current updates and recommendations on COVID and Monkeypox transmission. Read more below. COVID vaccines prevented poor
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna